Repetitive transarterial chemoembolization (rTACE) of hepatocellular carcinoma: Comparisons between an arterial port system and conventional angiographic technique

European Journal of Radiology

Volumn 51, Issue 1, 2004, Pages 6-11

  Hidajat, Nico ^a,b   Griesshaber, Volker ^a   Hildebrandt, Bert ^a   Hosten, Norbert ^a,c   Schröder, Ralf Jürgen ^a   Felix, Roland ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Chemoembolization; Cost analysis; Port; Radiation exposure

Indexed keywords

DIAGNOSIS; DISEASES; PATIENT MONITORING; RADIATION;

CATHETERIZATION; DOSE AREA PRODUCTS (DAP); REPETITIVE TRANSARTERIAL CHEMOEMBOLIZATION (RTACE);

RADIOLOGY;

CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; IODINATED POPPYSEED OIL; SODIUM CHLORIDE; STARCH MICROSPHERE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CATHETERIZATION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RADIATION EXPOSURE;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOGRAPHY, INTERVENTIONAL; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 2942571914     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2003.09.001     Document Type: Article

References (18)

1. Groupe d′Etude Et De Traitement Du Carcinome Hé patocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. New Engl. J. Med. 332:1995;1256-1261
2. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 359:2002;1734-1739
3. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 35:2002;1164-1171
4. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success - results from a liver transplantation center. Radiology. 214:2000;349-357
5. Iwamiya T., Sawada S., Ohta Y. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system. Cancer Chemother. Pharmacol. (Suppl). 33:1994;S134-S138
6. Tanikawa K. Non-invasive loco-regional therapy for hepatocellular carcinoma. Sem. Surg. Oncol. 12:1996;189-192
7. Kakizoe S., Kakizoe K., Kakizoe Y., Kakizoe H., Kakizoe T., Kakizoe S. Chemoembolization and prostaglandin E1 administration with use of hepatic arterial infusion port for the treatment of hepatocellular carcinoma and liver cirrhosis. Hepato-Gastroenterology. 43:1996;1377-1382
8. Ando E., Yamashita F., Tanaka M., Tanikawa K. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer. 79:1997;1890-1896
9. Hidajat N., Vogl T., Biamino G., et al. Radiation exposure in interventional radiology as exemplified by the chemoembolization of hepatocellular carcinoma and laser angioplasty of the pelvic arteries. Fortschr. Röntgenstr. 164:1996;249-256
10. Strecker E.P.K., Boos I.B.L., Ostheim-Dzerowycz W., Heber R., Vetter S.C. Percutaneously implantable catheter-port system: preliminary technical results. Radiology. 202:1997;574-577
11. Hirai K., Yamashita K., Aoki Y., et al. Assessment of therapeutic effects by transcatheter arterial embolization (TAE) in hepatic malignant tumors with degradable starch microspheres (DSM). Gan To Kagaku Ryoho. 15:(8 Pt.2):1988;2653-2658
12. Ando E., Tanaka M., Yamashita F., et al. Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus. J. Clin. Gastroenterol. 31:2000;247-249
13. Yamagami T., Kato T., Iida S., Tanaka O., Nishimura T. Withdrawal of implanted port-catheter for hepatic arterial infusion chemotherapy with fixed catheter tip technique. J. Vasc. Interv. Radiol. 14:2003;639-642
14. Berger D.H., Carrasco H., Hohn D.C., Curley S.A. Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J. Surg. Oncol. 60:1995;116-121
15. Herrmann K.A., Waggershauser T., Sittek H., Reiser M.F. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology. 215:2000;294-299
16. Ikebe M., Itasaka H., Adachi E., et al. New method of catheter-port system implantation in hepatic arterial infusion chemotherapy. Am. J. Surg. 186:2003;63-66
17. Puls R., Stroszczynski C., Hildebrandt B., et al. Radiological-guided liver-port implantation: evaluation, technical approach, interventional procedure and follow up. Fortschr. Röntgenstr. 173:2001;914-919
18. Seki H., Kimura M., Yoshimura N., Yamamoto S., Ozaki T., Sakai K. Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery. Clin. Radiol. 54:1999;221-227